Department of Psychiatry and Behavioral Sciences.

MSC 09 5030
1 University of New Mexico
Albuquerque, NM 87131

Phone: 505-272-2223

Grand Rounds:"50th Anniversary Presentation"

February 19, 2015

"Evaluating the Merit of Long Acting Antipsychotics in the Treatment of Schizophrenia: Does Design Matter:"

John C. Lauriello, MD, presents "Evaluating the Merit of Long Acting Antipsychotics in the Treatment of Schizophrenia:  Does Design Matter?" Lauriello is Robert J Douglas, MD and Betty Douglas Distinguished Faculty Scholar in Psychiatry and Professor and Chairman, Department of Psychiatry, University of Missouri. Before joining Missouri University in 2009, Lauriello served as UNM professor and vice chair of psychiatry. He directed the UNM Schizophrenia Research Group, which focuses on clinical trials and neuroimaging. He was executive medical director of the UNM Psychiatric Center for nearly a decade and served as a UNM site principal investigator for the Mental Illness and Neuroscience Discovery (MIND) Institute, a consortium of universities, schools of medicine, brain research institutions and laboratories in Minnesota, Massachusetts and New Mexico.

 Tuesday, February 24, 2015
1:00 pm - 2:00 pm
Domenici Center East Building, Auditorium, Rm. 1220.

OBJECTIVES:
At the end of this presentation the audience will be able to:
            1.  Understand the role of adherence in the treatment of schizophrenia
            2.  Be presented with the discrepant results of trials of long acting antipsychotics studies.
            3. Understand that design features may account for differing results of studies of long acting antipsychotics.
All psychiatrists, other physicians, fellows, residents, medical students and behavioral health providers  -- as well as members of the public -- are welcome to attend. Admission is free.

For more Grand Rounds information, click here